Executive Summary
Insulin resistance is one of the most prevalent yet underdiagnosed metabolic conditions of the 21st century. Affecting an estimated one in three adults globally, it is the silent upstream driver of Type 2 diabetes, non-alcoholic fatty liver disease (NAFLD), cardiovascular disease, polycystic ovarian syndrome (PCOS), cognitive decline, and several autoimmune conditions — years or even decades before clinical diagnosis.
Despite this outsized impact, public understanding of insulin resistance remains narrow, often reduced to a blood sugar problem. This white paper presents a comprehensive, accessible overview of what insulin resistance truly is: a whole-body metabolic syndrome with roots in modern lifestyle and profound consequences across multiple organ systems.
Written for the general reader, this paper combines clinical accuracy with plain-language explanations — so that science never becomes a barrier to understanding. Every technical term is explained in everyday language alongside it.
1. What Is Insulin Resistance?
1.1 The Role of Insulin in a Healthy Body
Insulin is a hormone — a chemical messenger — produced by specialised cells called beta cells in the pancreas. Its primary role is to act as a key that unlocks cells, particularly muscle cells and fat cells, allowing glucose (blood sugar) from the bloodstream to enter and be used for energy.
Beta cells: The specialised insulin-producing cells housed in the pancreas. Think of them as a factory that monitors your blood sugar and releases exactly the right amount of insulin in response.
When we eat carbohydrates, blood glucose rises. The pancreas detects this rise and releases insulin proportionally. Insulin then travels through the bloodstream and binds to receptors on cell surfaces, triggering a transporter protein called GLUT4 to move to the cell membrane and open a channel for glucose to enter. Once inside, glucose is either burned immediately for energy or stored as glycogen for later use.
GLUT4: A protein that acts like a door on the surface of muscle and fat cells. When insulin sends the signal, this door opens and allows glucose to pass from the blood into the cell. Without that signal, the door stays shut.
This elegantly controlled system keeps blood glucose within a narrow healthy range — typically 70 to 100 mg/dL — and ensures cells receive a steady energy supply.
1.2 When the Key Stops Working
Insulin resistance occurs when cells — primarily in the muscles, liver, and fat tissue — stop responding effectively to insulin's signal. The key still fits the lock, but it can no longer turn it. Glucose cannot efficiently enter the cells, so it remains elevated in the bloodstream.
The pancreas detects the elevated glucose and responds by producing more and more insulin — working harder to force the same response. For a period, this compensatory hyperinsulinaemia keeps blood glucose relatively normal, which is why routine tests often appear normal even when the problem is already advanced.
Hyperinsulinaemia: Chronically high levels of insulin in the blood. The pancreas is essentially overworking to compensate for cells that have stopped listening — like raising your voice louder and louder to someone wearing headphones.
This is why fasting blood glucose is the last biomarker to become abnormal. Insulin resistance can be severe for 5 to 10 years before glucose levels rise enough to trigger a clinical flag — meaning millions of people with advanced insulin resistance receive a clean bill of health on routine blood tests.
1.3 GLUT1 vs GLUT4 — Why the Brain Is Protected (Initially)
Not all cells in the body need insulin to absorb glucose. The brain and red blood cells use a different transporter called GLUT1, which operates independently of insulin — ensuring these critical organs maintain continuous glucose access regardless of insulin status. Muscle and fat cells, however, rely on GLUT4, which is insulin-dependent. This is why insulin resistance primarily disrupts muscle and fat cell function in its early stages, while leaving the brain's basic energy supply intact — though, as we will explore in Section 2.5, the brain is not permanently spared.
2. The Systemic Cascade: How One Problem Becomes Many
Insulin resistance is most accurately understood not as a single disease, but as a cascading metabolic syndrome — a chain reaction of interconnected disruptions that progressively affects the liver, pancreas, fat tissue, cardiovascular system, brain, gut, and immune system. Understanding this cascade transforms insulin resistance from an abstract medical term into a concrete, body-wide story.
2.1 The Liver: From Energy Manager to Fat Factory
When glucose cannot efficiently enter muscle cells, the bloodstream becomes flooded with excess glucose. The liver steps in and converts this surplus into fat through a process called de novo lipogenesis. Over time, fat accumulates within the liver itself — a condition called Non-Alcoholic Fatty Liver Disease (NAFLD), which now affects nearly one in three adults globally (global prevalence 30-32%, per 2023 meta-analysis data).
De novo lipogenesis: The process by which the liver converts excess blood sugar into fat. 'De novo' simply means 'from scratch.' When your cells refuse to absorb glucose, your liver essentially has no choice but to turn the overflow into fat — storing it where it should not be.
NAFLD (Non-Alcoholic Fatty Liver Disease): Fat building up inside the liver in someone who drinks little or no alcohol. The liver becomes greasy and inflamed, impairing its ability to manage blood sugar, process nutrients, and detoxify the body.
A fatty, insulin-resistant liver also loses the ability to respond to insulin's signal to pause glucose production overnight. The result is that the liver keeps releasing glucose into the blood even while you sleep — explaining why people with insulin resistance often show elevated fasting blood sugar in the morning despite not having eaten for 8 to 12 hours.
Hepatic glucose output: The liver releasing stored sugar into the bloodstream. In a healthy body, insulin signals the liver to stop this at night. In an insulin-resistant liver, that off-switch is broken — the liver keeps pouring sugar into the blood even while you sleep.
The liver also packages excess fat into particles called VLDL and releases them into the bloodstream, elevating triglycerides and suppressing HDL cholesterol — two hallmarks of metabolic syndrome that significantly raise cardiovascular risk.
Triglycerides and HDL: Triglycerides are fat particles circulating in your blood — high levels signal the liver is overloaded. HDL is the 'good cholesterol' that clears fatty deposits from arteries. In insulin resistance, triglycerides rise and HDL falls — a dangerous combination for the heart.
2.2 The Pancreas: An Organ Under Siege
Chronically overworked beta cells are producing two to five times the normal amount of insulin to compensate for cellular resistance. Sustained over years, this leads to progressive beta cell exhaustion and eventual beta cell loss. When the pancreas can no longer compensate sufficiently, blood glucose rises permanently — and Type 2 diabetes is formally diagnosed.
2.3 Visceral Fat: The Hidden Endocrine Organ
Perhaps the most paradigm-shifting discovery in metabolic medicine over the past two decades is that visceral fat — the fat stored around internal organs — is not passive storage. It is a biologically active endocrine organ that continuously secretes hormones and inflammatory molecules into the bloodstream.
Visceral fat: Fat stored deep inside the abdomen, wrapped around internal organs like the liver, kidneys and intestines. Unlike the fat you can pinch under your skin, visceral fat is invisible from the outside — and far more metabolically dangerous.
Endocrine organ: Any organ that produces and releases hormones directly into the bloodstream. We think of glands like the thyroid or pancreas as endocrine organs — but inflamed fat tissue behaves the same way, sending its own signals throughout the body.
| Molecule Released by Visceral Fat | What It Does to Your Body |
|---|---|
| TNF-alpha (inflammatory cytokine) | Directly blocks insulin receptor signalling — actively worsening resistance in every cell it reaches |
| IL-6 (inflammatory cytokine) | Promotes body-wide, low-grade inflammation that damages tissues over time |
| Resistin (hormone) | Drives further insulin resistance in the liver and muscles |
| Leptin in excess (hormone) | Creates leptin resistance — hunger signals become dysregulated, making it harder to feel full |
| Reduced Adiponectin (hormone) | Loss of this insulin-sensitising, anti-inflammatory hormone accelerates metabolic decline |
Cytokine: A chemical messenger released by immune cells or fat tissue. Some cytokines fight infection. The ones released by inflamed visceral fat do the opposite — they create chronic, low-level inflammation that damages healthy tissue over time.
Visceral fat drains directly into the portal vein — the blood vessel that feeds directly into the liver — meaning its toxic output hits the liver first, before reaching general circulation. This direct line makes visceral fat particularly destructive to liver function.
Portal vein: The large blood vessel that carries blood from the digestive organs directly to the liver. Visceral fat sits along this pathway, meaning everything it releases reaches the liver immediately and in high concentration — like pollution flowing directly into a water treatment plant.
Critically, visceral fat is not visible from the outside. Lean individuals can carry significant visceral fat — a phenomenon known as TOFI (Thin Outside, Fat Inside) — making waist circumference a far more reliable metabolic indicator than body weight alone.
2.4 The Cardiovascular System
The lipid dysregulation driven by insulin resistance creates an environment highly conducive to atherosclerosis. Chronic systemic inflammation from visceral fat further damages arterial walls. Hyperinsulinaemia itself stimulates sodium retention in the kidneys, driving hypertension (high blood pressure). Taken together, insulin resistance is one of the strongest independent risk factors for cardiovascular disease.
Atherosclerosis: The build-up of fatty plaques inside artery walls, progressively narrowing blood vessels. Think of it like limescale accumulating inside a pipe — over time, the flow is restricted, and eventually the pipe can block entirely. A blocked coronary artery causes a heart attack.
2.5 The Brain: Why Researchers Now Call It 'Type 3 Diabetes'
While the brain uses GLUT1 transporters for basic glucose supply independently of insulin, the brain also contains its own insulin receptors that govern critical functions entirely separate from glucose transport. These include synaptic plasticity (memory formation and consolidation), clearance of amyloid-beta plaques, dopamine regulation governing mood, and overall neuronal protection.
Synaptic plasticity: The brain's ability to form, strengthen, and reorganise connections between neurons — this is the physical basis of learning and memory. Insulin in the brain helps maintain and reinforce these connections.
Amyloid-beta plaques: Toxic protein fragments that accumulate between brain cells in Alzheimer's disease. A healthy brain continuously clears these fragments. Brain insulin resistance impairs the clearance mechanism — allowing plaques to build up.
Researchers now call Alzheimer's 'Type 3 Diabetes' to describe the pattern of brain insulin resistance observed in Alzheimer's patients. Multiple studies have demonstrated that improving systemic insulin sensitivity correlates with measurable improvements in cognitive biomarkers — making metabolic health an active frontier in dementia prevention.
2.6 The Gut and Immune System
The gut microbiome — the vast community of bacteria living in our digestive tract — plays a direct and bidirectional role in metabolic health. Beneficial gut bacteria ferment dietary fibre to produce Short Chain Fatty Acids (SCFAs) — particularly butyrate, propionate, and acetate — which travel to the liver and muscles and directly enhance insulin sensitivity.
Gut microbiome: The trillions of bacteria, fungi, and microorganisms living in your digestive system. Far from being passive residents, these organisms actively regulate digestion, immunity, inflammation, and — as we now know — insulin sensitivity.
Short Chain Fatty Acids (SCFAs): Beneficial molecules produced when gut bacteria digest dietary fibre. They are absorbed into the bloodstream and travel to the liver and muscles, where they act as metabolic helpers — reducing inflammation and directly improving insulin sensitivity.
Dysbiosis — an imbalance in gut bacteria — reduces SCFA production, increases intestinal permeability (sometimes called 'leaky gut'), and allows inflammatory molecules to flood the bloodstream, further driving insulin resistance. This gut-metabolic connection is one of the most active research frontiers in nutritional medicine.
Dysbiosis: An imbalance in the gut microbiome where harmful bacteria outnumber beneficial ones. This disrupts digestion, weakens the gut barrier, and sends inflammatory signals into the bloodstream — accelerating metabolic dysfunction.
Chronic metabolic inflammation also dysregulates the immune system over time, creating fertile ground for autoimmune conditions. Conditions including Hashimoto's Thyroiditis, PCOS, and Rheumatoid Arthritis are found disproportionately alongside insulin resistance — suggesting shared inflammatory pathways.
3. Root Causes: Why Insulin Resistance Has Become an Epidemic
Insulin resistance is not caused by a single factor — it is the convergence of several modern lifestyle forces acting simultaneously on the body's metabolic machinery. Understanding each cause is the first step toward dismantling them.
3.1 Diet: The Primary Fuel for the Fire
The modern diet — characterised by ultra-processed foods, refined carbohydrates, added sugars, and High Fructose Corn Syrup (HFCS) — creates chronic patterns of glucose and insulin spiking that the human body was not designed to handle at this frequency or magnitude.
Refined carbohydrates: Grains that have been processed to remove fibre, bran, and nutrients — leaving behind fast-digesting starch. White bread, white rice, and most packaged cereals are examples. Without fibre to slow absorption, they flood the bloodstream with glucose almost immediately after eating.
High Fructose Corn Syrup (HFCS): A cheap, highly processed sweetener derived from corn, used in the majority of packaged foods, soft drinks, and sauces. It is composed largely of fructose — a sugar that bypasses normal metabolic controls and goes directly to the liver, where it is converted to fat.
Fructose deserves particular attention. Unlike glucose, which is distributed and used by cells throughout the body, fructose is processed almost exclusively by the liver. The liver converts excess fructose directly to fat through de novo lipogenesis, generates uric acid as a toxic byproduct (raising blood pressure), and bypasses the satiety hormones that normally signal fullness. This makes HFCS — present in the vast majority of processed foods — one of the most metabolically destructive ingredients in the modern food supply.
3.2 Physical Inactivity
Skeletal muscle is the body's largest glucose sink — the biggest consumer of blood sugar. Physical movement, particularly resistance training, activates GLUT4 transporters through mechanical muscle contraction, completely independent of insulin. A sedentary lifestyle means this insulin-independent glucose clearance mechanism is chronically underused, placing the entire burden of glucose regulation on insulin alone. Regular resistance training can meaningfully upregulate GLUT4 expression for up to 48 hours post-exercise.
3.3 Sleep Deprivation
A single night of inadequate sleep (under 6 hours) has been shown to increase insulin resistance by approximately 25%. Chronic sleep deprivation keeps cortisol elevated overnight, causing the liver to continue glucose production through the night. It also dysregulates ghrelin (the hunger hormone that increases appetite) and leptin (the satiety hormone that signals fullness) — driving cravings for high-sugar foods the following day.
Cortisol: The body's primary stress hormone, produced by the adrenal glands. It is designed to spike briefly during danger, releasing stored glucose so muscles have energy to respond. When chronically elevated through stress or poor sleep, it continuously raises blood glucose — adding directly to the insulin burden.
3.4 Chronic Stress
Cortisol directly instructs the liver to release glucose into the bloodstream to prepare the body for perceived danger. Under chronic workplace, financial, or social stress, this mechanism runs persistently — creating a continuous low-level glucose flood that demands a continuous insulin response. No dietary intervention alone can fully counteract the metabolic effects of unmanaged chronic stress.
4. Early Detection: The Biomarker Dashboard
Standard annual blood tests check fasting glucose — but as we have established, this is the last marker to become abnormal. The following comprehensive biomarker panel enables early detection of insulin resistance, often years before diabetes is diagnosed. Ask your doctor to include these in your next blood test.
| Biomarker | What It Measures (Plain Language) | Optimal Range |
|---|---|---|
| Fasting Insulin | How hard your pancreas is working to manage blood sugar — high levels mean cells are resisting | Below 5 uIU/mL |
| HOMA-IR | A calculated resistance score using fasting insulin x glucose. Higher score = more resistance | Below 1.5 (ideal) |
| Fasting Blood Glucose | Your blood sugar level after an overnight fast | 70-90 mg/dL |
| HbA1c | Your average blood sugar over 3 months — glucose sticks to haemoglobin (red blood cell protein) | Below 5.4% |
| Triglycerides | Fat particles in blood — elevated when the liver is converting excess sugar to fat | Below 100 mg/dL |
| HDL Cholesterol | The 'good' cholesterol that clears arteries — falls as insulin resistance worsens | Above 60 mg/dL |
| hsCRP | Inflammation level in the body — elevated in insulin resistance and metabolic syndrome | Below 1.0 mg/L |
| ALT / SGPT | Liver enzyme — rises when liver cells are damaged by fat accumulation | Below 25 U/L |
| AST / SGOT | Liver enzyme — elevated in progressive liver inflammation | Below 25 U/L |
| Uric Acid | Byproduct of fructose metabolism — high levels signal metabolic stress | Below 5.5 mg/dL |
| Waist Circumference | The most reliable external indicator of dangerous visceral fat | Below 80 cm (women) / 90 cm (men) |
HbA1c: Haemoglobin A1c — haemoglobin is the protein in red blood cells that carries oxygen. Glucose slowly sticks to haemoglobin over time. Since red blood cells live for about 3 months, HbA1c gives a reliable 3-month average of your blood sugar levels.
hsCRP (high-sensitivity C-Reactive Protein): A protein produced by the liver whenever there is inflammation anywhere in the body. 'High-sensitivity' means the test can detect even very low levels of inflammation — making it an early warning system for metabolic and cardiovascular disease.
5. The Reversal Protocol: Evidence-Based Interventions
Insulin resistance — for most people in early to moderate stages — is a fully reversible condition. The same daily forces that built it can be redirected to dismantle it. The following four-pillar protocol is grounded in clinical research and refined through 13 years of patient outcomes.
5.1 Pillar One: Nutritional Strategy
Carbohydrate Quality Over Quantity
The solution is not to eliminate carbohydrates but to replace refined carbohydrates with whole, fibre-rich alternatives. Whole grains, legumes, and vegetables digest slowly, releasing glucose gradually rather than in a sudden flood. Their fibre content also acts as a prebiotic — feeding beneficial gut bacteria that produce insulin-sensitising SCFAs.
Prebiotic: Food that nourishes beneficial bacteria in your gut. Fibre from whole grains, legumes, and vegetables acts as fuel for these bacteria — which, in return, produce compounds that directly improve your metabolic health.
Meal Sequencing — A Simple, Powerful Habit
The order in which food is consumed significantly impacts the post-meal glucose response. Eating fibre-rich vegetables first, then protein, then carbohydrates reduces post-meal glucose spikes by 30 to 40% compared to eating carbohydrates first — with no change in food choices or portions. Fibre and protein slow down the stomach's emptying process and coat the gut lining before carbohydrates arrive, fundamentally changing how fast glucose enters the blood.
Protein and Healthy Fats
Both cause minimal insulin release, slow digestion, and extend satiety. Healthy fats from olive oil, avocado, nuts, and fatty fish carry anti-inflammatory properties that directly counter the inflammation driving insulin resistance. Omega-3 fatty acids — found in salmon, sardines, walnuts, and flaxseed — are particularly beneficial.
Meal Timing and Time-Restricted Eating
Every time food is consumed, insulin is released. Eating across a 15-hour window (from breakfast to a late-night snack) means insulin is elevated for most of the day, giving cells no rest period to resensitise. Restricting the eating window to 10 to 12 hours — for example, eating only between 8am and 8pm — provides an extended overnight rest that allows insulin levels to fall and cells to recover sensitivity. This requires no calorie restriction, no special foods, simply a time boundary.
Foods to Include and Eliminate
| Include Regularly | Eliminate or Minimise |
|---|---|
| Leafy greens and non-starchy vegetables | Ultra-processed and packaged foods |
| Whole grains (oats, quinoa, millets, barley) | Refined flours, white rice, white bread |
| Legumes (lentils, chickpeas, kidney beans) | Added sugars and High Fructose Corn Syrup |
| Fatty fish (salmon, sardines, mackerel) | Fruit juices and sweetened beverages |
| Nuts and seeds (almonds, walnuts, flaxseed) | Fried foods and industrial seed oils |
| Fermented foods (yogurt, kefir, kimchi) | Artificial sweeteners in excess |
| Whole fruit — never juice | Late-night eating after 7-8 PM |
| Olive oil and avocado | Alcohol in excess |
5.2 Pillar Two: Exercise — The Most Underutilised Metabolic Medicine
Physical activity — particularly resistance training — is one of the most powerful interventions for insulin resistance, operating through mechanisms entirely independent of diet. Muscle contraction activates GLUT4 transporters without requiring insulin, directly clearing glucose from the bloodstream and rebuilding the body's largest glucose sink.
- Resistance training (weight training, bodyweight exercises): Minimum 3 to 4 sessions per week. Directly upregulates GLUT4 expression in muscles for up to 48 hours post-exercise.
- Post-meal walking: A 10-minute walk after each meal activates muscular glucose uptake and reduces post-meal glucose spikes by 20 to 30%. Three such walks daily represents a significant cumulative metabolic benefit — no gym required.
- High Intensity Interval Training (HIIT): 20 to 30-minute sessions twice weekly demonstrate superior insulin-sensitising effects compared to equivalent-duration steady-state cardio.
- Break prolonged sitting: Brief movement every 60 to 90 minutes independently improves insulin sensitivity beyond formal exercise sessions.
5.3 Pillar Three: Sleep Optimisation
Seven to eight hours of quality sleep per night is a metabolic intervention — not a lifestyle luxury. During deep sleep, cortisol reaches its lowest levels, the liver pauses glucose production, growth hormone facilitates cellular repair, and hunger hormones reset to healthy baselines.
- Maintain a consistent sleep and wake schedule, including weekends.
- Avoid bright screen exposure for 60 minutes before bed — blue light suppresses melatonin and disrupts the cortisol rhythm.
- Keep the bedroom cool (18 to 20 degrees Celsius) and dark — independently associated with deeper, more restorative sleep.
- Avoid eating within 2 to 3 hours of sleep — this allows insulin to return to baseline before the overnight fasting window begins.
5.4 Pillar Four: Stress Management
Because cortisol directly raises blood glucose through hepatic glucose release, chronic unmanaged stress is a direct metabolic liability that dietary changes alone cannot offset. Stress management must be treated as a clinical intervention.
- Structured breaks: Brief movement or breathing breaks every 60 to 90 minutes interrupt cortisol accumulation during sedentary work periods.
- Mindfulness and meditation: Even 10 minutes of daily breath-focused practice demonstrates measurable reductions in cortisol levels and inflammatory markers in randomised controlled trials.
- Nature exposure: Time spent in green spaces is independently associated with reduced cortisol, lower blood pressure, and improved sleep quality.
- Social connection: Chronic loneliness activates the same cortisol and inflammatory pathways as physical threat — meaningful relationships are a physiological health intervention.
6. Five Dangerous Myths About Insulin Resistance
7. Conclusion
Insulin resistance is not a diagnosis to fear. It is information — the body's way of communicating, through an escalating series of metabolic signals, that the inputs it has been receiving are misaligned with what it needs to function optimally.
What makes insulin resistance both significant and actionable is its position at the root of so many chronic diseases that define modern health. Cardiovascular disease, Type 2 diabetes, non-alcoholic fatty liver disease, cognitive decline, and multiple autoimmune conditions all share insulin resistance as a common upstream driver. Addressing it does not just prevent one disease — it simultaneously reduces the risk of an entire constellation of conditions.
The evidence is unambiguous: the human body is designed for metabolic resilience. When given the right inputs — whole food nutrition, regular movement, restorative sleep, and managed stress — it demonstrates a remarkable capacity to reverse even advanced insulin resistance. Clinical studies document significant improvements in insulin sensitivity, liver fat, inflammatory markers, and body composition within 8 to 12 weeks of consistent lifestyle intervention.
About the Author
Shilpa Ashish Bhoskar is a Nutritionist with over 13 years of specialised clinical experience in pre-diabetes reversal and diabetes control. Her practice is built on a single conviction: that metabolic disease is not inevitable, and that most patients who receive a pre-diabetes or early diabetes diagnosis can reverse course through targeted, evidence-based lifestyle interventions — without defaulting to medication as a first resort.
Over her career, Shilpa has guided hundreds of patients through metabolic recovery — improving fasting insulin, reducing visceral fat, restoring liver health, and achieving sustained reversal of pre-diabetic markers. Her work sits at the intersection of clinical nutritional science and public health education, translating complex metabolic research into accessible, practical guidance that patients can actually implement in their daily lives.
[Activénse Holistic Solutions Pvt. Ltd.] | [ www.activense.com & www.glycosutra.com ] | [activensepune@gmail.com]
Key References & Further Reading
All references below are peer-reviewed, publicly accessible sources. Click any link to access the full study.
1. [Lifestyle intervention reduces Type 2 diabetes by 58%]
Knowler WC et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine. 2002;346(6):393-403. https://www.nejm.org/doi/full/10.1056/NEJMoa012512
2. [Post-meal 10-minute walk reduces postprandial glucose spikes]
Positive impact of a 10-min walk immediately after glucose intake on postprandial glucose levels. Scientific Reports. 2025. https://www.nature.com/articles/s41598-025-07312-y
3. [Meal sequencing (vegetables first) reduces glucose spikes 30-40%]
The impact of food order on postprandial glycemic excursions in prediabetes. BMJ Open Diabetes Research & Care. 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7398578/
4. [Single night of sleep deprivation induces ~25% insulin resistance]
Donga E et al. A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways. Journal of Clinical Endocrinology & Metabolism. 2010;95(6):2963-8. https://academic.oup.com/jcem/article/95/6/2963/2598810
5. [Alzheimer's disease as Type 3 Diabetes — brain insulin resistance]
de la Monte SM, Wands JR. Alzheimer's Disease Is Type 3 Diabetes — Evidence Reviewed. Journal of Diabetes Science and Technology. 2008;2(6):1101-1113. https://journals.sagepub.com/doi/10.1177/193229680800200619
6. [NAFLD global prevalence — nearly 1 in 3 adults (30-32%)]
Quek J et al. Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis. Lancet Gastroenterology & Hepatology. 2023. https://pubmed.ncbi.nlm.nih.gov/36626630/
7. [Visceral fat as active endocrine organ — adipokines and insulin resistance]
Kershaw EE, Flier JS. Adipose Tissue as an Endocrine Organ. Journal of Clinical Endocrinology & Metabolism. 2004. | Adipokines Mediate Inflammation and Insulin Resistance. Frontiers in Immunology. 2013. https://pmc.ncbi.nlm.nih.gov/articles/PMC3679475/
8. [Fructose drives de novo lipogenesis and fatty liver disease]
Softic S et al. Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease. Digestive Diseases and Sciences. 2016;61(5):1282-1293. https://pmc.ncbi.nlm.nih.gov/articles/PMC4838515/
9. [Short-chain fatty acids (SCFAs) and insulin sensitivity — systematic review]
Den Besten G et al. Short-chain fatty acids and insulin sensitivity: a systematic review and meta-analysis. Nutrition Reviews. 2024;82(2):193-209. https://pmc.ncbi.nlm.nih.gov/articles/PMC10777678/
10. [Gut microbiome, SCFAs and Type 2 diabetes — dietary fibre connection]
Sonnenburg JL, Backhed F. Diet-microbiota interactions as moderators of human metabolism. Nature. 2016;535(7610):56-64. https://pmc.ncbi.nlm.nih.gov/articles/PMC6715624/
11. [Global prevalence of metabolic syndrome and insulin resistance]
Worldwide trends in metabolic syndrome from 2000 to 2023: a systematic review and modelling analysis. Nature Communications. 2025. https://www.nature.com/articles/s41467-025-67268-5
12. [HOMA-IR — validated clinical tool for insulin resistance assessment]
Matthews DR et al. Homeostasis model assessment: insulin resistance and beta-cell function. Diabetologia. 1985;28:412-419. | MDCalc HOMA-IR Calculator. https://www.mdcalc.com/calc/3120/homa-ir-homeostatic-model-assessment-insulin-resistance
13. [Resistance training and GLUT4 upregulation — enhanced insulin sensitivity]
Prior exercise redistributes intramuscular GLUT4 and enhances insulin-stimulated GLUT4 translocation. Molecular Metabolism. 2020. https://pmc.ncbi.nlm.nih.gov/articles/PMC7240215/
14. [Mechanisms of insulin action and insulin resistance]
Petersen MC, Shulman GI. Mechanisms of Insulin Action and Insulin Resistance. Physiological Reviews. 2018;98(4):2133-2223. https://pubmed.ncbi.nlm.nih.gov/29634284/
15. [Chronic inflammation, metaflammation and metabolic disease]
Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177-185. https://pubmed.ncbi.nlm.nih.gov/28179656/
(c) 2026 Shilpa Ashish Bhoskar. All Rights Reserved.